Top Italian Life Sciences Company selects ValGenesis’ SaaS platform to digitally manage its validation processes
San Francisco, June 15, 2021 – ValGenesis Inc., a market…
ValGenesis Inc. Secures $24 Million Investment from Morgan Stanley Expansion Capital
San Francisco, May 04, 2021 ValGenesis, Inc., the market leader…
American cell therapies company selects ValGenesis VLMS to digitize multiple validation lifecycle processes
San Francisco, January 25, 2021: ValGenesis Inc., a market leader…
International biosciences company to digitize validation processes for its clients across 40 countries, driven by ValGenesis VLMS
San Francisco, January 20, 2021: ValGenesis, Inc., a market leader…
Pioneering Gene Therapy Company selects ValGenesis’s SaaS platform to digitize its global validation programs
San Francisco, January 6, 2021: ValGenesis, Inc., a market leader…
ValGenesis collaborates with Biocon Biologics for digital validation across multiple sites
San Francisco, December 15, 2020: ValGenesis Inc., a market leader…
Global medical devices company went live with paperless validation process across the organization, powered by ValGenesis SaaS platform
San Francisco, December 7, 2020: ValGenesis, Inc., a market leader…
Global Top 5 life science organization selects ValGenesis to digitize and standardize validation processes across its global sites
San Francisco, November 18, 2020: ValGenesis, Inc., a market leader…
Global clinical-stage biopharmaceutical company selects ValGenesis to digitize its corporate validation process
San Francisco, October 27, 2020: ValGenesis, Inc., a market leader…
